M
Mnemo Therapeutics
Biotech & Life Sciences · Paris, France · Founded 2019
Developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. EnfiniT platform, a groundbreaking drug discovery engine MoreLess
MNEMO specializes in providing robust data protection solutions that ensure compliance with global privacy regulations, including the General Data Protection Regulation (GDPR) and the French Data Protection Act. The company serves a diverse range of clients, including businesses and organizations that handle sensitive personal data and require stringent data security measures. Operating primarily in the data protection and cybersecurity market, MNEMO's business model focuses on offering tailored solutions that safeguard personal data against breaches and unauthorized access. The company generates revenue through subscription-based services, consulting fees, and implementation of data protection frameworks. MNEMO's services are designed to meet the specific needs of clients, ensuring that their data management practices align with legal requirements and industry standards. The company also leverages advanced analytics tools, such as Google Analytics, to enhance its service offerings and provide clients with actionable insights. Additionally, MNEMO maintains a global presence with affiliates in New York, ensuring that it can support clients with international data transfer needs while adhering to applicable regulations.
Keywords: data protection, GDPR compliance, cybersecurity, personal data, privacy regulations, data security, consulting services, global presence, analytics, legal compliance.
Company overview
Mnemo Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Low Activity
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 0.0
Valuation & funding
Mnemo Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jun 2021 | $83M | $330M | Casdin Capital · Redmile Group · Alexandria Venture Investments · Emerson Collective | ↗ |
| SEEDOther financing | Dec 2020 | $0 | — | Casdin Capital | — |
| SPINOUTOther financing | Jan 2019 | $0 | — | PSL University · Institut Curie | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 11 |
| 2025 | 17 |
| 2024 | 32 |
| 2023 | 44 |
| 2022 | 60 |
| 2021 | 27 |
Growth signals
Mnemo Therapeutics website traffic
Latest recorded traffic for Mnemo Therapeutics is 240 monthly website visits, down 68.8% over the last three months. Mnemo Therapeutics's team declined 35.3% over the past year.
Comparisons
Mnemo Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Mnemo Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Mnemo Therapeutics has talent and traffic
team presence
In the news
Latest news about Mnemo Therapeutics
Recent press, funding announcements, and product moves mentioning Mnemo Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Mnemo Therapeutics
An AI-synthesized read of the highest-engagement posts about Mnemo Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mnemo Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.














